Authors
Hao Zhang, Robert I Horne, Z Faidon Brotzakis, Charles Harris, Pietro Liò, Michele Vendruscolo
Published in
The journal of physical chemistry letters. Volume 17. Issue 45. Pages 12864-12870. Nov 12, 2026.
Abstract
The process of α-synuclein aggregation results in the formation of amyloid deposits that accumulate in the brain of patients affected by Parkinson's disease and related synucleinopathies. Among possible therapeutic strategies for these conditions, one approach is based on the development of compounds capable of inhibiting α-synuclein aggregation. An effective inhibition could be achieved by blocking the nucleation sites on the surface of the amyloid fibrils that are responsible for their autocatalytic proliferation. Here, we use an E(3)-equivariant conditional diffusion model to identify candidate inhibitors of this type. With this approach, we generated pocket-conditioned molecules, identified purchasable analogues, and experimentally tested selected compounds. We thus identified a compound that delays α-synuclein aggregation under conditions in which secondary nucleation is the dominant process. These results illustrate the use of conditional diffusion models to identify candidate aggregation inhibitors.
PMID:
43018333
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0